New test for symptomless pancreatic cancer has 97 per cent accuracy, fuelling hopes deadly disease could be caught in earliest stages

A new test for symptomless pancreatic cancer has been developed with 97 percent accuracy, offering hope for early detection and treatment of the disease. The test could potentially catch the disease in its earliest stages, improving patient outcomes. This breakthrough may lead to increased survival rates for those affected by pancreatic cancer.